全文获取类型
收费全文 | 88468篇 |
免费 | 5977篇 |
国内免费 | 3179篇 |
专业分类
耳鼻咽喉 | 1663篇 |
儿科学 | 6009篇 |
妇产科学 | 818篇 |
基础医学 | 5795篇 |
口腔科学 | 857篇 |
临床医学 | 11043篇 |
内科学 | 7205篇 |
皮肤病学 | 522篇 |
神经病学 | 12903篇 |
特种医学 | 3044篇 |
外国民族医学 | 4篇 |
外科学 | 5929篇 |
综合类 | 16057篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 8490篇 |
眼科学 | 1082篇 |
药学 | 8383篇 |
109篇 | |
中国医学 | 6579篇 |
肿瘤学 | 1127篇 |
出版年
2024年 | 94篇 |
2023年 | 1336篇 |
2022年 | 2194篇 |
2021年 | 3548篇 |
2020年 | 3383篇 |
2019年 | 2919篇 |
2018年 | 2988篇 |
2017年 | 3034篇 |
2016年 | 3405篇 |
2015年 | 3060篇 |
2014年 | 6517篇 |
2013年 | 6364篇 |
2012年 | 5907篇 |
2011年 | 6100篇 |
2010年 | 4926篇 |
2009年 | 4415篇 |
2008年 | 4379篇 |
2007年 | 4455篇 |
2006年 | 3939篇 |
2005年 | 3338篇 |
2004年 | 2794篇 |
2003年 | 2541篇 |
2002年 | 1970篇 |
2001年 | 1864篇 |
2000年 | 1629篇 |
1999年 | 1377篇 |
1998年 | 997篇 |
1997年 | 899篇 |
1996年 | 753篇 |
1995年 | 710篇 |
1994年 | 676篇 |
1993年 | 517篇 |
1992年 | 431篇 |
1991年 | 426篇 |
1990年 | 378篇 |
1989年 | 353篇 |
1988年 | 283篇 |
1987年 | 255篇 |
1986年 | 216篇 |
1985年 | 363篇 |
1984年 | 300篇 |
1983年 | 212篇 |
1982年 | 257篇 |
1981年 | 240篇 |
1980年 | 196篇 |
1979年 | 143篇 |
1978年 | 124篇 |
1977年 | 82篇 |
1976年 | 100篇 |
1974年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Clinical characteristics of pediatric patients with COVID-19 between Omicron era vs. pre-Omicron era
《Journal of infection and chemotherapy》2022,28(11):1501-1505
IntroductionDetailed data on clinical characteristics in children with the omicron strain of SARS-COV-2 are limited.MethodsWe conducted a retrospective observational study of children with COVID-19 at the National Center for Child Health and Development to evaluate the clinical manifestations during and before the emergence of the omicron variant. Only symptomatic patients without underlying diseases were included. Participants were divided into two temporal groups: the “omicron era” (1/2022–2/2022) and the “pre-omicron era,” where the delta variant predominated (7/2021–11/2021). The patients were subclassified into an older vaccine-eligible group (aged 12–17 years), a younger vaccine-eligible group (aged 5–11 years), and a vaccine-ineligible group (aged 0–4 years).ResultsWe compared 113 patients in the omicron era with 106 in the pre-omicron era. Most patients in both eras had non-severe disease, and no patients required mechanical ventilation or died. Among patients aged 0–4 years, sore throat and hoarseness were more common during the omicron era than the pre-omicron era (11.1% vs. 0.0% and 11.1% vs. 1.5%, respectively). Croup syndrome was diagnosed in all patients with hoarseness. Among patients aged 5–11 years, vomiting was more frequent during the omicron era (47.2%) than during the pre-omicron era (21.7%). Cough and rhinorrhea were less common during the omicron era in patients aged 0–4 and 5–11 years, respectively, than during the pre-omicron era.ConclusionsIn children with COVID-19, clinical manifestations differed between the omicron and pre-omicron eras. In the Omicron era, croup syndrome was more frequent in vaccine-ineligible children. 相似文献
2.
3.
目的 研究凉血通瘀方对高血压大鼠急性脑出血模型脑组织miRNA表达的影响,对差异表达的miRNA靶基因进行分析,探索凉血通瘀方可能的药效机制。方法 将自发性高血压大鼠随机分成对照组(B)和实验组(C)。适应性饲养一周后,C组灌胃凉血通瘀方,B组灌胃等体积生理盐水,连续5天,每天1次。构建脑出血模型后收集脑组织,借助全转录组测序技术获得miRNA表达量,与miRBase数据库比对获取已知miRNA,使用miRDeep2预测新miRNA。差异分析软件为DESeq2,筛选阈值为|log2FC| ≥1 并且P <0.05。对显著差异表达的miRNA进行靶基因预测,对靶基因进行GO功能、KEGG通路富集和PPI网络分析。结果 实验组和对照组对比,共发现21个显著差异表达的miRNA,上调有9个,下调有12个,共预测得到1243个有统计学意义的靶基因。GO富集分析发现,生物过程中突触囊泡分泌的调节、神经递质分泌的调节和神经递质运输的调节占前三位,神经元投射终点、全膜、质膜区域和细胞投射则是主要的细胞成分。分子功能分别为小GTPase绑定、底物特异性跨膜转运蛋白活性和离子跨膜转运体活性。通路分析结果显示,靶基因在癌证通路、pI3K-Akt信号通路、人类乳头瘤病毒感染、神经活性配体-受体相互作用和MAPK通路等分布广泛。采用STRING网站和Cytoscape软件,根据MCC算法筛选出ADRA2C、CASR、CCL28、CCR1、DRD2、GNAT3、GRM2、DYNC1LI1、GABBR1、GNAI1等核心靶基因。结论 凉血通瘀方对脑出血急性期鼠脑组织内miRNA的表达有重要影响;显著差异表达miRNAs可能通过靶向核心基因调控凉血通瘀方干预急性脑出血的病理过程及预后。 相似文献
4.
《European annals of otorhinolaryngology, head and neck diseases》2022,139(6):351-356
ObjectivesSystematic review of the scientific literature dedicated to treatment modalities and results for aural tuberculosis published since the start of the 21st century.Material and methodsSearch of the Medline, Cochrane and Embase databases for the period 2000 - 2020. Selection of articles in English, French and Spanish devoted to clinical cases and series documenting treatment of auricular tuberculosis. Extraction of data on pre-established files documenting treatment modalities and results. Reading of articles by two authors. Analysis performed according to SWiM guidelines, evaluating cure, tuberculosis-related death, treatment-related complications, improvement in facial palsy, and hearing sequelae rates.ResultsOne hundred and twenty eight articles: 118 case reports (159 patients) and 10 cohorts (177 patients) from 42 countries were analyzed. Female/male sex ratio was 1.2 with ages ranging from 1 month to 87 years. Medical treatment consisted in 5 to 24 months’ antitubercular antibiotic treatment using 2 to 8 antibiotics. Mastoidectomy, tympanoplasty and facial nerve decompression were associated to medical treatment in 64.7%, 17.4% and 6.2% of cases, respectively. Overall rates of cure, death, treatment-related complications, facial sequelae and hearing sequelae were 96.8%, 2%, 9.5%, 35.8% and 75.5%. In case reports, BCG vaccination did not appear to protect against facial palsy and severe intracranial complications (P > 0.6). There was no significant correlation (P > 0.3) between death and the clinical variables tested, and facial nerve decompression did not appear to influence outcome for facial function (P = 0.4).ConclusionMedical treatment is very effective but not without risk of death, complications and sequelae. It is the same as for pulmonary tuberculosis. Indications for and benefit of major auricular surgery during medical treatment deserve further studies. 相似文献
5.
6.
7.
摘要:目的 探讨儿童肺炎克雷伯菌血流感染(Klebsiella pneumoniae bloodstream infection, KPBSI)临床特征及肺炎克雷伯
菌(Klebsiella pneumoniae, KP)对常用抗菌药物的敏感性,为儿童KPBSI合理治疗提供参考。方法 回顾性分析2014年1月至2019
年12月在重庆医科大学附属儿童医院住院的KPBSI患儿临床资料。结果 共纳入110例患儿,64例(58.2%)为院内感染,72例
(65.5%)有基础疾病,以血液系统肿瘤最多见。110例患儿PRISM Ⅲ评分为16.0(7.0~20.8),其中74例(67.3%)发生脓毒症,15例
(13.6%)发生脓毒性休克,18例(16.4%)发生呼吸衰竭,15例(13.6%)需有创机械通气,院内死亡共13例(11.8%)。KP菌株对阿米卡
星、碳青霉烯类抗菌药物敏感率>90%,对头孢噻肟、头孢曲松和头孢他啶的敏感率分别为58.3%、60.9%和70.9%,对头孢哌
酮/舒巴坦和哌拉西林/他唑巴坦的敏感率分别为59.5%和82.7%。检出ESBLs+菌株39株(39/86,45.3%),耐碳青霉烯类肺炎克雷
伯菌(CRKP)菌株10株(10/110,9.1%),ESBLs+KP菌株和CRKP在各年龄组间分布无统计学差异。结论 儿童KPBSI多见于有基
础疾病的患儿,脓毒症、脓毒性休克和呼吸衰竭发生率高;KP菌株对头孢他啶和哌拉西林/他唑巴坦敏感性较高,可经验性治
疗轻症KPBSI患儿。 相似文献
8.
9.
《Vaccine》2022,40(18):2525-2527
10.